At HRS 2026, Dr. Song Zuo presented evidence that AI can detect atrial fibrillation with over 90% sensitivity, ...
Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI(TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...
BELLEVUE, Wash.--(BUSINESS WIRE)--Sudden Cardiac Arrest (SCA) is the leading medical cause of death in young athletes during sport. The presence of congenital abnormalities and electrical ...
KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Insight, Inc., a U.S. developer of wearable medical devices and diagnostic software, announced today that the company has secured its first cardiology ...
SANTA CLARA, Calif., July 22, 2025--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, ...
In a study of patients with cutaneous sarcoidosis, ECG abnormalities identified all cases of cardiac involvement, demonstrating 100% sensitivity and 100% negative predictive value. Researchers ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack ...
Wearable biosensor Inventors Peter Elango and Madhu Bhaskaran holding the dry electrodes, part of the RMIT ECG device. (Courtesy: Seamus Daniel, RMIT University) Conventional electrocardiograms (ECG) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results